We are thrilled to announce that Bebop, a pioneering decentralized trading platform, has successfully raised $5,500,000 in its latest funding round. This significant capital boost will enable us to further our commitment to revolutionizing the user experience and execution standards in the decentralized finance (DeFi) sector. At Bebop, we envision a future where financial transactions are not only accessible but also intuitive and efficient. Despite the tremendous potential of DeFi, we recognize existing barriers that hinder widespread adoption, and our mission is to break these barriers down. The latest funding will specifically be focused on developing superior trading products that cater to a wider audience, ensuring that every user, regardless of their prior experience in trading, can take advantage of DeFi’s incredible opportunities. Bebop is proud to be scrutinized and shaped by market veterans; our team comprises experienced DeFi traders and talented developers who understand the intricacies of the industry. We are also excited to share that our platform has been incubated by Wintermute, a leading liquidity powerhouse in digital assets that provides us with invaluable resources and insights. As we propel forward with this funding, our dedication remains firm - to empower individuals with the tools they need to navigate the evolving landscape of finance. Stay tuned for further updates as we embark on this exciting journey in making DeFi accessible and efficient for everyone!

Bebop Secures $5.5 Million in Funding to Revolutionize DeFi Trading Experience
Get the full Bebop company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Arkenstone Defense
Arkenstone exists to remove execution friction between modern technology companies and the U.S. national security ecosystem. Arkenstone is a dual-layered federal business back office infrastructure for compliance, HR, and contracting. Foundation is the federal contracting eligibility layer - closing compliance gaps, getting you audit-ready, and keeping you qualified to win and maintain contracts. Cohort is the operating and scaling layer - handling workforce, payroll, and labor compliance so you can execute without risking performance or margin. Learn how Arkenstone can accelerate your mission with our back office infrastructure.
$35.0M Seed
today

Quaise Energy
Quaise develops superhot geothermal power plants for a terawatt-scale world. Our unique millimeter wave drilling system can build geothermal wells at unprecedented temperatures and depths, unlocking energy security and independence for every nation. By targeting temperatures of 300-500 degrees Celsius at depths of 3-20 kilometers, we can build power generation and heat distribution plants within a short distance of every major population and industrial center on the planet. We can even achieve the terawatt-level annual deployments required to meet accelerating global energy demand by scaling through the fossil fuel industry's established supply chain and workforce. There is no other energy solution capable of the same scale and speed.
$134.0M Series b
today

deelan
At Deelan.ai, we're reinventing how teams learn with AI at the very core of our platform. Gone are the days of slow, one-size-fits-all training. Now, you can create full learning programs with courses, role-plays, workshops, and even AI-led webinars using just a single prompt. Designed for founders, sales leaders, and HR teams, Deelan.ai turns your knowledge, documents, and needs into custom training in minutes not months. Our chat-first interface eliminates complex dashboards, making training creation lightning-fast, intuitive, and accessible with no previous expertise required. Whether you're onboarding new hires, boosting commercial skills, or scaling learning across your organization, Deelan empowers teams with structured, impactful, and fully customizable training built to drive performance and all with transparent small-team pricing.
$790.0K Seed
today

invitrolize
Our in vitro model allows for the first time the identification and differentiation of respiratory sensitizers and respiratory irritants under air-liquid interphase realistic exposure conditions.
$2.8M Seed
today

Exobiosphere
The world's first space focused pre-clinical contract research organization. Our mission is to extend and improve life on Earth and in Space. We use microgravity as a new dimension for biology to accelerate drug discovery and unlock therapies that are very hard or even impossible to develop on Earth. We’re building the world’s first standardized space-based high-throughput testing platform, allowing pharma and biotech partners to run automated experiments in orbit, at scale. By combining microgravity with advanced lab automation and bioinformatics, we create more physiologically relevant models, observe faster disease development, and reach enhanced 3D biology compared to standard in-vitro systems. The goal is simple: make space a routine, essential part of the biomedical R&D pipeline so we can bring better and faster treatments to patients.
$10.0M Seed
today